Transcatheter Aortic Valve Replacement (TAVR) is now approved for use in patients with severe aortic valve stenosis who are at intermediate or greater risk for open heart surgery. The procedure gives Deborah’s surgical and interventional teams a sophisticated, minimally invasive catheter-based treatment option for repairing stenotic aortic valves—without traditional open-heart surgery.
Conducted within Deborah’s Hybrid Operating Room, this approach is a viable option for patients who are at intermediate or greater risk for an open-heart procedure. TAVR represents a new standard in the quality of patient care.
The Facts About Aortic Valve Disease:
- The cause of 25,000 deaths each year
- 7% of the population of the age of 65 is affected
- 2 years after the diagnosis of severe aortic stenosis, untreated patients have a survival rate as low as 50%